FDA rejected Moderna’s mRNA flu vaccine due to flawed trial design and comparator, raising concerns over regulatory consistency and innovation.

A promising nasal spray vaccine in mice offers broad, long-lasting protection against flu, COVID-19, colds, pneumonia, and allergens with just one dose, potentially eliminating annual shots, but human trials are still needed.

Women experience longer pain after injury due to biological differences in immune cells, a study finds.

Cats and humans share key cancer genes, with study revealing similar tumor mutations and treatment responses, advancing precision medicine for both.

Johnson & Johnson invests $1B in Pennsylvania to build a cell therapy plant, creating 4,500 jobs, part of a broader U.S. push for domestic advanced medicine manufacturing.

FDA to shift from two to one clinical trial for most new drug approvals to accelerate access.

A new blood test may predict Alzheimer’s onset within 3–4 years, but isn’t yet reliable for healthy people.

A Tetris-like game played after recalling trauma cuts flashbacks by 90%, offering a simple, scalable PTSD tool.

FDA approves new oral combo for untreated CLL, showing better outcomes than chemo.

A small 2026 trial found DMT therapy rapidly reduced depression symptoms for up to six months in treatment-resistant adults.